DrugPatentWatch Archives

You are currently viewing the 2010 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: kanamycin sulfate

Summary for Generic Name: kanamycin sulfate

Drug Master File Entries: see list4
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Clinical Trials for: kanamycin sulfate

Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents
Status: Completed Condition: Healthy

Patients Response to Early Switch To Oral:Osteomyelitis Study
Status: Not yet recruiting Condition: Osteomyelitis

Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics
Status: Completed Condition: Colorectal Neoplasms

Brief Bactericidal Activity of Anti-Tuberculosis Drugs
Status: Not yet recruiting Condition: Tuberculosis; Drug-resistant Tuberculosis; Multidrug-resistant Tuberculosis

High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis
Status: Completed Condition: Tuberculosis, Multidrug-Resistant

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
Status: Active, not recruiting Condition: Mycobacterium Avium-Intracellulare Infection

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
Status: Temporarily not available Condition: Tuberculosis

Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis
Status: Completed Condition: Tuberculosis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
kanamycin sulfate
CAPSULE; ORAL060516Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
kanamycin sulfate
CAPSULE; ORAL061911Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
kanamycin sulfate
CAPSULE; ORAL062726Mar 6, 1987DISCNNo<disabled><disabled>
Baxter Hlthcare
kanamycin sulfate
INJECTABLE; INJECTION062324Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology